Table 1.
Positive rate of total and C‐12 tumor markers in the 3 groups (%)
| Group | Number | Total positive rate (positive cases) | CA199 | NSE | CEA | CA242 | Ferritin | β‐HCG | AFP | f‐PSA | PSA | CA125 | HGH | CA153 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lung cancer | 224 | 77.23 (180) | 37.05a | 9.82a | 61.16a | 21.07a | 17.41a | 3.13 | 4.46 | 4.91a | 3.13 | 70.98a | 0.45 | 10.71a |
| Hospitalized | 159 | 13.84 (22) | 18.87b | 3.77b | 35.22b | 9.43b | 22.01b | 1.26 | 2.52 | 5.66a | 4.40 | 74.21a | 0 | 5.66b |
| Control | 123 | 9.76 (12) | 4.76c | 0c | 2.38c | 0c | 0c | 0 | 0 | 0c | 2.38 | 2.38c | 0 | 0c |
In the same column, different number (eg, a and b, b and c, a and c) showed there was significant difference between the lung cancer, hospitalized and control group (P < .05). In the same column, the same number (eg, a and a, b and b, c and c) showed there was no significant difference between the lung cancer, hospitalized and control group (P > .05).